KEAP1 and prostate carcinoma: Overall, our in vitro results have demonstrated that ALA can affect two cellular pathways playing a significant role in the progression of prostate carcinoma: Nrf2/Keap1/p62 and autophagy machinery, as recently highlighted in the literature [6,49].